SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-048169
Filing Date
2020-10-28
Accepted
2020-10-28 08:08:40
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20200930.htm   iXBRL 10-Q 2335006
2 EX-31.1 crsp-ex311_9.htm EX-31.1 18970
3 EX-31.2 crsp-ex312_7.htm EX-31.2 19174
4 EX-32.1 crsp-ex321_8.htm EX-32.1 8207
  Complete submission text file 0001564590-20-048169.txt   8634967

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crsp-20200930.xsd EX-101.SCH 57763
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20200930_cal.xml EX-101.CAL 55654
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20200930_def.xml EX-101.DEF 175560
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20200930_lab.xml EX-101.LAB 435203
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20200930_pre.xml EX-101.PRE 319649
10 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20200930_htm.xml XML 1708932
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 201266258
SIC: 2836 Biological Products, (No Diagnostic Substances)